Aldermore (ALD) Share Price

Conversion Price. The conversion price shall be 80% of the average closing price of the Company’s common stock over the last five (5) trading days prior to conversion (the “Conversion Price”).

I believe the shares are restricted for 6 months as they are not registered shares.

This post is dedicated to you, Home-Girl, read it, learn it and use the Actipatch for your issues ( i mean it did help your frost bitten tongue, from your own admission here, no?? )

BIEL$$$
( Lets see how high our beloved BIEL gets TRUMPed up by Jan. 1, before NOPAIN Act is act

Wonderful! Thank you for that update! Let's hope that we get some sort of SANE ruling. Don't want the first ever ISDA Master Agreement for CDS $5T market to be walked out on!

INBS IS EXPERIENCING GRADUAL GREEN VOLUME INFUSION. NORHTBOUND MIGHT BE SPORADIC

I took another entry @ $2.54, 4:35am . 4:34am was lower bollinger band followed by conformation candle. Now I hold

INBS has a nice catalyst

I am not sure if I-Hub admin is sleeping on these imposters ...

Why is this stock opening hogh? I thought it was dead

ARE U STILL IN "INBS" OR ALL OUT*******WHLS" WAS ONE OF A KIND MOVE. THE 4AM TRADE WAS A PERFECT SET UP. EXCELLENT PRICE ACTION, ONE NEVER KNOW WHEN SUCH WILL MATERIALIZE AGAIN.

First ask them about your impersonation and take their vote on your accountability and then ask questions
Otherwise, at least I have a few civil court judgements but you are an intimidating criminal publicly impersonating my daughter ...
still having no shame ...

Why is this stock opening hogh? I thought it was dead

Electromountain,

“ Some others´ intentions aren´t that clear, encouraging people into buying this stock for years while it only went down.”

I guess your message on ‘ intentions’ was meant for me, since I used a Churchill quote.
I met you for the first time early

🤦‍♂️

C4 Therapeutics to Present Preliminary CFT1946 Monotherapy Phase 1 Clinical Data at the European Society for Medical Oncology (ESMO) Congress 2024
Abstract Released Today Highlights Favorable Safety Profile and Early Evidence of Monotherapy Anti-Tumor Activity

Investor Webcast

$INBS +67% @ 2.64. Hit 3.29, see chart. All action has been in after and pre markets.

See how this crosses the rubicon...

https://investorshub.advfn.com/uimage/uploads/2024/9/9/jlthg0_-_inbs_chart_all_action_in_aft_and_pre_market_090924.pn

$INBS +62% @ 2.56, see chart. All action has been in after and pre markets.

See how this crosses the rubicon...

https://investorshub.advfn.com/uimage/uploads/2024/9/9/jlthg0_-_inbs_chart_all_action_in_aft_and_pre_market_090924.png

With regards to this issue people should pay attention to what Dan specifically said in the interview regarding FFMG being taken out too cheap: "I don't think there is a scenario where Keith Neumeyer wants this company to be bought out too cheap. I think there is always another path for us to take t

INBS waiting for second entry...Stock1ace1 I'm not pumping

VS trading sideways, waiting for volume

Happy Trading

Who is "we"?

Oops! 😃

Pennies to Pirate You all know what is up! Only a few. Hope not true. you can edit but ....only edit...what you know Just like .micro..nano..edit. and thank you for 911 to . Now we don't have personality

Decentralized Currency

Go $AABB

Laxmi, Within year 2024, there are 2 court judgements, and one active fraudulent case against you, and in San Mateo county , California alone. These are your "accomplishments" in the short 3 years since you moved to San Mateo county. Your "accomplishments" before moving to San Mateo county are equal

IVP moving

Target Market Segments
1. Individual Investors
MyGold’s low entry barriers and fractional ownership make it an ideal choice for retail investors looking to diversify their portfolios with gold. Unlike traditional gold investments that require significant capital, MyGold allows individu

At 6GSymposium, InterDigital to Lead Crucial Discussions on Emerging Use Cases and Avenues Towards 6G Profitability
Company Release - 9/9/2024
CTO Rajesh Pankaj and Head of Wireless Labs Milind Kulkarni among speakers as InterDigital returns as Symposium partner
WILMINGTON, Del.

INBS a quick 60%

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175052015

Nextech3D.ai Secures Three New Patents for AI-Powered 3D Model Generation Algorithms
Growing Portfolio Now Includes a Total of Five Patents In the Field of 3D Modeling

TORONTO, ON / ACCESSWIRE / September 4, 2024 / Nextech3D.ai (OTCQX:NEXCF)(CSE:NTAR)(FSE:1SS), a leading provid